Dr. Janice Y. Maldonado, MD

Dr. Maldonado practices at USFCenter for Advanced Healthcare in Tampa, Florida.

Dr. Maldonado's NPI, 1639199748, was assigned on July 20, 2006. Dr. Maldonado graduated from University of Puerto Rico, Medical Sciences Campus in 1992. Dr. Maldonado holds Florida license ME85373.

Dr. Maldonado's primary practice is USFCenter for Advanced Healthcare, at 13330 Usf Laurel Dr, Tampa, FL 33612 in Hillsborough County. The practice phone is (813) 974-2201.

Dr. Maldonado's primary practice is USFCenter for Advanced Healthcare in Tampa, Florida. Dr. Maldonado is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Maldonado to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maldonado practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Maldonado's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Maldonado is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Maldonado's licenses on file in 3 states: Florida, New Mexico and Maryland.

Dmand AI lists migraine and chronic headache and multiple sclerosis among the conditions Dr. Maldonado treats.

CMS data shows 9,017 Medicare services from Dr. Maldonado across 5 procedure codes in 2024, for 126 Medicare patients. Medicare paid $57,430 for them. Every service was in an office.

CMS counts 126 Medicare patients who saw Dr. Maldonado in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Maldonado's median patient age at 57, with 78% women.

In 2024, Dr. Maldonado wrote 2,623 Medicare Part D claims for 294 patients. 71% of them were for generic drugs. CMS names the drug for 2,370 of them, across 53 drugs with 11 or more claims each, at $1,923,468 in total drug cost. In 2023, CMS named 2,366 claims across 53 drugs.

Dr. Maldonado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maldonado as offering telehealth.

Dmand AI links 8 papers to Dr. Maldonado, published from 2004 to 2024. Dr. Maldonado has published most often in Int J MS Care. Dr. Maldonado's most frequent co-authors are Derrick Scott Robertson, MD, Silvia R. Delgado and Natalie Moreo.

Dmand AI links Dr. Maldonado to 1 clinical trial. Conditions studied include Multiple Sclerosis, Chronic Progressive and Multiple Sclerosis, Relapsing-Remitting. Open Payments lists research payments to Dr. Maldonado that name 1 trial.

CMS Open Payments shows 60 general payments to Dr. Maldonado from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $445. It also lists 1 research payment totaling $1,850 in 2024, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Maldonado, most recently CMS Stage 1 EHR in 2013.

Dr. Maldonado graduated from University of Puerto Rico, Medical Sciences Campus in 1992.

Dr. Maldonado is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.